Biotech Gainers: Xencor Inc (NASDAQ:XNCR), Pacific Biosciences of California (NASDAQ:PACB), Endocyte (NASDAQ:ECYT), Incyte Corporation (NASDAQ:INCY)

Xencor, Inc. (NASDAQ:XNCR) is unchanged at $11.73, with 934,368 shares traded. As reported by Zacks, the current mean recommendation for XNCR is in the “strong buy range”. Xencor Inc (NASDAQ:XNCR) stock performance was 11.18% in last session and finished the day at $11.73. Traded volume was 1.86million shares in the last session and the average volume of the stock remained 132.02K shares. Xencor Inc (NASDAQ:XNCR) … Continue reading Biotech Gainers: Xencor Inc (NASDAQ:XNCR), Pacific Biosciences of California (NASDAQ:PACB), Endocyte (NASDAQ:ECYT), Incyte Corporation (NASDAQ:INCY)

Kevin Long04/0104/01

Biotech Most Active Stocks: Gilead Sciences (NASDAQ:GILD), EXACT Sciences Corporation (NASDAQ:EXAS), Endocyte (NASDAQ:ECYT), Arena Pharmaceuticals (NASDAQ:ARNA)

Gilead Sciences Inc. (NASDAQ:GILD) announced that it has elected to settle its conversion obligations in connection with any 1.00% Senior Convertible Notes due 2014 (the “Notes”) submitted for conversion on or after February 1 2014 entirely in cash. Gilead Sciences, Inc. (NASDAQ:GILD) stock performance was -4.01% in last session and finished the day at $68.55. Traded volume was 29.25million shares in the last session and … Continue reading Biotech Most Active Stocks: Gilead Sciences (NASDAQ:GILD), EXACT Sciences Corporation (NASDAQ:EXAS), Endocyte (NASDAQ:ECYT), Arena Pharmaceuticals (NASDAQ:ARNA)

Kevin Long03/3103/31

Small Cap Active Stocks: FuelCell Energy (NASDAQ:FCEL), Ariad Pharmaceuticals (NASDAQ:ARIA), KB Home (NYSE:KBH), Endocyte (NASDAQ:ECYT)

Shares of Plug Power Inc. (NASDAQ:FCEL) fell 9% on Friday, and the stock was moving toward ending the week down nearly 20% as investors’ enthusiasm for it seemed to have dried up — at least for now. FuelCell Energy Inc (NASDAQ:FCEL) stock performance was 6.64% in last session and finished the day at $2.57. Traded volume was 29.87million shares in the last session and the … Continue reading Small Cap Active Stocks: FuelCell Energy (NASDAQ:FCEL), Ariad Pharmaceuticals (NASDAQ:ARIA), KB Home (NYSE:KBH), Endocyte (NASDAQ:ECYT)

Colin Pettis03/2403/24

Trending Tickers : Halliburton Company (NYSE:HAL), ArcelorMittal SA (ADR) (NYSE:MT), Columbia Property Trust, Inc. (NYSE:CXP), Coherent Inc. (NASDAQ:COHR), Endocyte, Inc. (NASDAQ:ECYT)

On Oct 21, As fracking accelerates in North American shale fields, oilfield services providers Halliburton Company (NYSE:HAL) and Baker Hughes Inc are stockpiling sand to protect themselves against rising costs and are buying more railcars to transport the haul. Halliburton Company (NYSE:HAL) belongs to Basic Materials sector. Its net profit margin is 10.70% and weekly performance is -1.00%. On last trading day company shares ended … Continue reading Trending Tickers : Halliburton Company (NYSE:HAL), ArcelorMittal SA (ADR) (NYSE:MT), Columbia Property Trust, Inc. (NYSE:CXP), Coherent Inc. (NASDAQ:COHR), Endocyte, Inc. (NASDAQ:ECYT)

Mark Doerr10/28

Trader’s Watch List: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Chesapeake Energy Corporation (NYSE:CHK), Envivio, Inc. (NASDAQ:ENVI), Mannatech, Incorporated (NASDAQ:MTEX), Endocyte, Inc. (NASDAQ:ECYT)

Amicus Therapeutics (NASDAQ:FOLD) COO Bradley L. Campbell unloaded 18,750 shares of the company’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $5.40, for a total transaction of $101,250.00. Following the completion of the transaction, the chief operating officer now directly owns 200,000 shares in the company, valued at approximately $1,080,000. Amicus Therapeutics, Inc. (NASDAQ:FOLD) … Continue reading Trader’s Watch List: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Chesapeake Energy Corporation (NYSE:CHK), Envivio, Inc. (NASDAQ:ENVI), Mannatech, Incorporated (NASDAQ:MTEX), Endocyte, Inc. (NASDAQ:ECYT)

Colin Pettis08/22

NASDAQ Losers: ON Semiconductor Corp (NASDAQ:ONNN), Endocyte (NASDAQ:ECYT), Actuate Corp (NASDAQ:BIRT), Merrimack Pharmaceuticals (NASDAQ:MACK)

ON Semiconductor Corp (NASDAQ:ONNN)’s adjusted earnings totaled $75.2 million, or 17 cents a share, while revenue increased year over year to $706.5 million from $661 million. Analysts polled by Thomson Reuters expected the company to earn 15 cents a share on revenue of $711.67 million. The company issued second-quarter revenue guidance in the range of $738 million to $768 million. ON Semiconductor Corp (NASDAQ:ONNN) stock … Continue reading NASDAQ Losers: ON Semiconductor Corp (NASDAQ:ONNN), Endocyte (NASDAQ:ECYT), Actuate Corp (NASDAQ:BIRT), Merrimack Pharmaceuticals (NASDAQ:MACK)

Colin Pettis05/05